Pune: Serum Institute's Cervavac Receives WHO Prequalification

Pune: Serum Institute's Cervavac Receives WHO Prequalification

Get latest articles and stories on India at LatestLY. India’s first indigenously developed Human Papillomavirus (HPV) vaccine, Cervavac, manufactured by the Serum Institute of India (SII), received prequalification from the World Health Organisation (WHO).  India News | Pune: Serum Institute's Cervavac Receives WHO Prequalification.

India’s HPV vaccine Cervavac gets WHO’s safety nod

Previously approved for its use in India by the drug controller, Cervavac is administered for the prevention of diseases caused by the four HPV types

Serum Institute’s Cervavac HPV vaccine receives WHO prequalification

Serum Institute’s Cervavac, India’s first indigenously developed HPV vaccine, has received WHO prequalification, allowing UN agencies to procure it globally.

CERVAVAC receives WHO prequalification

Serum Institute of India’s CERVAVAC, the country’s first indigenously developed gender-neutral quadrivalent human papillomavirus vaccine, has received prequalification from the World Health Organization (WHO)